Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$3.5M
-11.3% from 2023
Prescriptions
1,348
$2,624.94 per claim
Patients
279
329 prescribers
Total spending, 2024
$3.5M
$12,682.53 per patient
Medicare prescription drug plans paid $3.5M for Arimidex in 2024, for 1,348 prescriptions and refills to 279 patients (down 11.3% from 2023). The average cost per claim was $2,624.94.
New York had the highest Medicare cost for Arimidex in 2024: $543K for 203 claims, followed by California ($531K).
Caroline A Rivera Olmo, hematology-oncology in Vega Baja, PR, had the highest Medicare cost for Arimidex in 2024: 52 claims costing $92K.
Arimidex is made by ANI Pharmaceuticals, Inc. (ANIP), listed in the Medicare spending data as Ani Pharmaceuti.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Caroline A Rivera Olmo Vega Baja, PR | Hematology-Oncology | 52 | Under 11 | $92K |
| Stanley E Waintraub Hackensack, NJ | Hematology-Oncology | 25 | Under 11 | $60K |
| Christine S Iovino |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 381 | 1,563 | 342 | $4.3M |
| 2023 | 347 | 1,477 | 311 | $4.0M |
| 2024 | 329 | 1,348 | 279 | $3.5M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 17 |
| Under 11 |
| $54K |
| Monica Santiago Casiano Yauco, Puerto Rico, PR | Hematology-Oncology | 31 | Under 11 | $51K |
| Linda T Vahdat Lebanon, NH | Medical Oncology | 18 | Under 11 | $36K |
| Ellen H Chirichella Anchorage, AK | Hematology-Oncology | 14 | Under 11 | $28K |
| Laura C Farrington Zion, IL | Medical Oncology | 12 | Under 11 | $23K |
| Travis Koeneke Manhattan, KS | Hematology-Oncology | 12 | Under 11 | $22K |
| Yelitza Ruiz Bayamon, PR | Internal Medicine | 13 | Under 11 | $21K |
| Joanna Rodriguez Philadelphia, PA | Hematology-Oncology | 13 | Under 11 | $20K |
| Roberto Velazquez Torres Ponce, PR | Hematology-Oncology | 12 | Under 11 | $20K |
| Irene Kuter Boston, MA | Hematology-Oncology | 12 | Under 11 | $20K |
| Amber Thompson Uniontown, PA | Nurse Practitioner | 12 | Under 11 | $20K |
| Michael J Keefer Oklahoma City, OK | Medical Oncology | 12 | Under 11 | $19K |
| Christopher M McCanless Baton Rouge, LA | Internal Medicine | 12 | Under 11 | $19K |
| Michael W Meshad Mobile, AL | Medical Oncology | 12 | Under 11 | $19K |
| Paul B Bader Rego Park, NY | Hematology-Oncology | 12 | Under 11 | $18K |
| James C Rucinski Brooklyn, NY | General Surgery | 12 | Under 11 | $18K |
| Monika L Burness Ann Arbor, MI | Medical Oncology | 11 | Under 11 | $18K |
| Diane D Wilder Little Rock, AR | Medical Oncology | 11 | Under 11 | $17K |
| Jenny C Chang Houston, TX | Medical Oncology | 11 | Under 11 | $17K |
| Merrick I Ross Houston, TX | General Surgery | 11 | Under 11 | $16K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Ani Pharmaceuti ANIP | 1,348 | $3.5M |